TY - JOUR
T1 - Multi-institutional Outcomes for Simultaneous and Staged Urinary and Fecal Diversions in Patients Without Cancer
AU - The Neurogenic Bladder Research Group
AU - Barboglio Romo, Paholo G.
AU - Santiago-Lastra, Yahir
AU - Myers, Jeremy B.
AU - Pathak, Piyush
AU - Elliott, Sean P.
AU - Cotter, Katherine J.
AU - Stoffel, John T.
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/8
Y1 - 2018/8
N2 - Objective: To compare the morbidity and postoperative recovery between patients treated with urinary diversion after colostomy with patients undergoing simultaneous double diversion (DD). Methods: A multi-institutional retrospective review was performed in patients treated with urinary diversion after colostomy or simultaneous DD between 2007 and 2014 for noncancerous indications. The Clavien-Dindo system was used to classify complications occurring within 90 days of surgery, and high-grade adverse events (HGAE) were classified grade 3 or higher. Results: A total of 46 patients were identified with fecal and urinary diversions (19 in the after colostomy (AC) group, 27 in the DD group). Common indications for urinary diversion were neurogenic bladder (54%) and urinary fistula (44%). Mean hospital stay and return of bowel function after surgery for entire cohort was 13 and 7 days, respectively, with no differences between AC and DD groups. Almost 50% of patients in the cohort experienced an HGAE but there was no difference in HGAE incidence (8/19 AC, 13/27 DD; P =.69) or complication type between the groups. Increased operative time (5% risk per every 15 minutes over 7 hours, P =.03) was the only independent variable associated with increased risk of HGAE. DD was not independently associated with increased risk of HGAE compared with staged urinary diversion. Conclusion: Morbidity and postoperative recovery appeared similar whether urinary diversion is performed after colostomy or during a DD.
AB - Objective: To compare the morbidity and postoperative recovery between patients treated with urinary diversion after colostomy with patients undergoing simultaneous double diversion (DD). Methods: A multi-institutional retrospective review was performed in patients treated with urinary diversion after colostomy or simultaneous DD between 2007 and 2014 for noncancerous indications. The Clavien-Dindo system was used to classify complications occurring within 90 days of surgery, and high-grade adverse events (HGAE) were classified grade 3 or higher. Results: A total of 46 patients were identified with fecal and urinary diversions (19 in the after colostomy (AC) group, 27 in the DD group). Common indications for urinary diversion were neurogenic bladder (54%) and urinary fistula (44%). Mean hospital stay and return of bowel function after surgery for entire cohort was 13 and 7 days, respectively, with no differences between AC and DD groups. Almost 50% of patients in the cohort experienced an HGAE but there was no difference in HGAE incidence (8/19 AC, 13/27 DD; P =.69) or complication type between the groups. Increased operative time (5% risk per every 15 minutes over 7 hours, P =.03) was the only independent variable associated with increased risk of HGAE. DD was not independently associated with increased risk of HGAE compared with staged urinary diversion. Conclusion: Morbidity and postoperative recovery appeared similar whether urinary diversion is performed after colostomy or during a DD.
UR - http://www.scopus.com/inward/record.url?scp=85049072632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049072632&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2017.11.057
DO - 10.1016/j.urology.2017.11.057
M3 - Article
C2 - 29366642
AN - SCOPUS:85049072632
VL - 118
SP - 202
EP - 207
JO - Urology
JF - Urology
SN - 0090-4295
ER -